Skip to main content

B2Gold Releases its Tenth Annual Responsible Mining Report and its Fifth Annual Climate Strategy Report

VANCOUVER, British Columbia, May 25, 2026 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO) (NYSE AMERICAN: BTG) (NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce that it has published its tenth annual Responsible Mining Report entitled “Raising the Bar” (the “Report”), which details B2Gold’s global economic contributions and its environmental, social, and governance management practices, together with the Company’s performance against key indicators in 2025. Highlights of the Report are presented below, and full details are outlined in the Report, which is available to view or download at the link provided below. All dollar figures are in United States dollars unless otherwise indicated.  B2Gold is also pleased to announce that it has published its 2025 Climate Strategy Report. The Climate Strategy Report presents...

Continue reading

G2 Goldfields Announces Filing and Mailing of Meeting Materials in Connection With the Acquisition by G Mining Ventures and Spin-Out With G3 Goldfields

TORONTO, May 25, 2026 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX:GTWO; OTCQX:GUYGF) is pleased to announce that it has filed the management information circular (the “Circular”) and related meeting materials (collectively, the “Meeting Materials”) for the special meeting of the holders of common shares of G2 (the “G2 Shareholders”) to be held on June 16, 2026 (the “Meeting”). The mailing of the Meeting Materials to G2 Shareholders has commenced, and the Meeting Materials are also available on the Company’s website at www.g2goldfields.com and under the Company’s profile on SEDAR+ at www.sedarplus.ca. The Arrangement On April 9, 2026, G2 entered into a definitive agreement with G Mining Ventures Corp. (“GMIN”) and G3 Goldfields Inc. (“G3”) pursuant to which GMIN will acquire all of the common shares of G2...

Continue reading

Regenx Provides Update on OTC Markets Trading Status and Audit Progress

EDMONTON, Alberta, May 25, 2026 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Company” or “Regenx“) (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) announces that effective May 18, 2026, the Company’s U.S. ticker symbol RGXTF was reassigned by OTC Markets Group from the OTCQB Venture Market to the OTC Expert Market. The Company was not notified of this reassignment in advance and identified the change through a corporate action posting. As previously disclosed, the Company has been subject to a cease trade order issued by the Alberta Securities Commission (the “ASC”), the Company’s principal regulator, effective October 1, 2025, for failing to file its audited annual financial statements, management’s discussion and analysis, and related certifications for the fiscal year ended March 31, 2025 (collectively,...

Continue reading

Dime Expands Williamsburg Presence with Acquisition of Former Signature Bank Space

HAUPPAUGE, N.Y., May 25, 2026 (GLOBE NEWSWIRE) — Dime today announced the expansion of its Williamsburg footprint with the signing of a lease for a prominent banking space formerly occupied by Signature Bank. The space is owned by the Forman Family, who are also the owners of Peter Luger Steak House – one of New York City’s most iconic institutions and a valued client of Dime. The expansion underscores Dime’s continued investment in Brooklyn and its long-term commitment to serving local businesses, residents, and community organizations throughout Williamsburg and the surrounding neighborhoods. Located in the heart of Williamsburg, the new space at 185 Broadway will enhance Dime’s ability to provide personalized and private banking services to its clients. The expansion also reflects Dime’s strategic growth initiatives following...

Continue reading

LECTRA: Share buyback program – Aggregated disclosure of transactions in own shares carried out from May 18 to May 22, 2026

Share buyback program Aggregated disclosure of transactions in own sharescarried out from May 18 to May 22, 2026 Paris, May 25, 2026, Pursuant to the authorization granted by the Combined Shareholders’ Meeting held on April 29, 2026, to operate on its shares and in accordance with the regulations relating to share buybacks, Lectra SA (LEI: 9695000KWQEBUDT6IO19) announces below the transactions in its own shares (LSS – FR0000065484) carried out from May 18 to May 22, 2026:Issuer Name Transaction Date Financial Instrument Identifier Code Total Daily Volume (number of shares) Daily Volume Weighted Average Acquisition Price (€) Market(MIC Code)LECTRA 18/05/2026 FR0000065484 11,521 16.0383 XPARLECTRA 18/05/2026 FR0000065484 8,093 16.0504 CEUXLECTRA 18/05/2026 FR0000065484 1,134 16.0242 TQEXLECTRA 18/05/2026 FR0000065484 1,559 16.0433 AQEULECTRA 19/05/2026 FR0000065484 13,902 16.3799 XPARLECTRA 19/05/2026 FR0000065484 8,392 16.3438 CEUXLECTRA 19/05/2026 FR0000065484 1,627 16.3104 AQEULECTRA 19/05/2026 FR0000065484 1,160 16.2909 TQEXLECTRA 20/05/2026 FR0000065484 13,356 16.1894 XPARLECTRA 20/05/2026 FR0000065484 7,379 16.2018 CEUXLECTRA 20/05/2026 FR0000065484 1,297 16.1984 AQEULECTRA 20/05/2026 FR0000065484 1,040 16.2294 TQEXLECTRA 21/05/2026 FR0000065484 14,829 16.3247 XPARLECTRA 21/05/2026 FR0000065484 1,568 16.4063 AQEULECTRA 21/05/2026 FR0000065484 9,850 16.4006 CEUXLECTRA 21/05/2026 FR0000065484 1,102 16.4099 TQEXLECTRA 22/05/2026 FR0000065484 8,996 16.6043 XPARLECTRA 22/05/2026 FR0000065484 2,974 16.5918 CEUXLECTRA 22/05/2026 FR0000065484 1,113 16.6037 TQEXLECTRA 22/05/2026 FR0000065484 1,658 16.5891 AQEU    TOTAL 112,550 16.2947  About...

Continue reading

GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026  

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 25, 2026 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today highlights its broad participation at EASL Congress 2026. This visibility reflects both its scientific momentum and its active involvement in the ACLF ecosystem, as well as its position at an inflection point in MASH, while also highlighting the continuous progress made in PBC, driven by its partner Ipsen. I.      GENFIT Posters Seven posters have been accepted for presentation at EASL Congress mainly covering GENFIT’s key assets positioned in Acute on-Chronic Liver Failure (ACLF) and including GENFIT’s latest work on Real-World data in ACLF. ACLF – Scientific DataPoster FRI-384: G1090N –...

Continue reading

AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share

PRESS RELEASE FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE Paris, May 25, 2026, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share. Maxim Group issued this recommendation in a research update entitled “2H25 Review/Outlook: With Masitinib Clinical Trial Insurance Policy Offer, Positioned to Initiate Phase 3 Study for ALS in 2H26”, published on 21 May 2026. In this update, Maxim Group reiterated its recommendation to buy the stock,...

Continue reading

Air Canada Foundation Publishes 2025 Impact Report on Advancing the Health and Well-Being of Children and Youth Across Canada

MONTRÉAL, May 25, 2026 (GLOBE NEWSWIRE) — The Air Canada Foundation today released its 2025 Impact Report, outlining the meaningful difference it made in communities across Canada through its charitable partnerships, fundraising initiatives and the engagement of Air Canada employees nationwide.Through its programs and collaborations with Canadian-registered charities, the Foundation remains committed to improving the health and well-being of children and youth. Its work is guided by three core pillars: Health, supporting pediatric hospitals and community organizations to improve health outcomes; Protection, addressing socio-economic adversity and the impacts of trauma so children can experience a healthy childhood; and Dreams, fostering hope and resilience for seriously ill, impoverished or vulnerable children. “In 2025, the...

Continue reading

Interim consolidated financial statement of Grigeo Group AB covering 3 months of 2026

Over 3 months of 2025, Grigeo Group AB company group (hereinafter – the Group), consisting of Grigeo Group AB, Grigeo Packaging UAB, Grigeo Baltwood UAB, Grigeo Klaipėda AB, Mena Pak AT, Grigeo Recycling UAB, Grigeo Recycling SIA, Grigeo Paper Packaging UAB, Grigeo Tissue UAB, Grigeo Hygiene UAB, Huchtemeier Papier GmbH, Grigeo Tissue sp. z o.o and Energia Cieplna Niedomice sp. z o.o achieved the consolidated sales turnover of EUR 77.5 million. It is by EUR 18.4 million more than over respective period of 2025. Over the reporting period, the Group earned EUR 2.4 million profit before taxes, which is by EUR 2.1 million less than in the same period in 2025. Earnings before interest, taxes, depreciation, and amortization (EBITDA) of the Group, if compared with 3 months of 2025, decreased by EUR 1.6 million and reached EUR 5.9 million. The...

Continue reading

PharmaCorp Announces Definitive Agreement to Acquire PharmaChoice Canada Bannered Pharmacy in Ontario

Purchase price of approximately $8.2 million The acquisition represents a continued expansion of PharmaCorp’s footprint in OntarioSASKATOON, Saskatchewan, May 25, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy acquisition and ownership platform for pharmacist-led community pharmacy ownership, today announced that it has entered into a definitive share purchase agreement, dated May 22, 2026 (the “Agreement”) to acquire from an arm’s length vendor group a 100% interest in a PharmaChoice Canada bannered pharmacy located in Morrisburg, Ontario (the “Acquisition”). The Acquisition continues the expansion of the Corporation’s geographical footprint and operating scale. Further to PharmaCorp’s acquisition pipeline update announced in its press release dated April 30,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.